Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Robert Borchert - Senior Vice President, Investor and Corporate Communications Shawn Morris - Chief Executive Officer David Mountcastle - Executive Vice President and Chief Financial Officer Parth Mehrotra - President and Chief Operating Officer Conference Call Participants Joshua Raskin - Nephron Research LLC Albert Rice - Credit Suisse AG Lisa Gill - JPMorgan Chase & Co. Adam Ron - Bank ...

2 nd Quarter 2022 Results August 11, 2022 Shawn Morris – Chief Executive Officer Parth Mehrotra – President & COO David Mountcastle – Chief Financial Officer 1 Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2022 financial guidance and other projections and forecasts. These forward ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Robert Borchert – Senior Vice President-Investor and Corporate Communications Shawn Morris – Chief Executive Officer Parth Mehrotra – President and Chief Operating Officer David Mountcastle – Chief Financial Officer Conference Call Participants Josh Raskin – Nephron Research A.J. Rice – Credit Suisse Lisa Gill – J.P. Morgan Ryan Daniels – William Blair Whit Mayo – SVB Securities Jessica Tass ...

1 st Quarter 2022 Results May 12, 2022 Shawn Morris – Chief Executive Officer Parth Mehrotra – President & COO David Mountcastle – Chief Financial Officer 1 Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2022 financial guidance and other projections and forecasts. These forward-lo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-K _______________________________ Commission file number 001-40365 _________________________ Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) _________________________ (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 950 N. Glebe Rd., Suite 700 Arlington, Virginia 22203 (Mark One) ☒ ANNUAL REPORT PURSUAN ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2021 Earnings Conference Call March 23, 2022 8:30 AM ET Company Participants Robert Borchert - SVP, Investor and Corporate Communications Shawn Morris - CEO David Mountcastle - CFO Parth Mehrotra - President and COO Conference Call Participants Josh Raskin - Nephron Research Whit Mayo - SVB Leerink Jailendra Singh - Credit Suisse Lisa Gill - JPMorgan Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity Nick Spiekhout - William Blair Operator Good ...

SPRIVIA 1 H E A L T H 4 th Quarter & Full Year 2021 Results March 23, 2022 Shawn Morris – Chief Executive Officer Parth Mehrotra – President & COO David Mountcastle – Chief Financial Officer Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2022 financial guidance and other projectio ...

| --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Empowering Physicians | | | | | | | | TRANSFORMING | | | | | | | | J.P. Morgan Healthcare Conference January 10, 2022 HEALTHCARE | | | | | | | | | | | | | | | | | | | | | | | Disclaimer Forward-Looking Statements This presen ...